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Abstract
Mitochondria can depolarize and trigger cell death through the opening of the mitochondrial permeability transition pore
(MPTP). We recently showed that an increase in the long chain n3 polyunsaturated fatty acids (PUFA) docosahexaenoic acid
(DHA; 22:6n3) and depletion of the n6 PUFA arachidonic acid (ARA; 20:4n6) in mitochondrial membranes is associated with a
greater Ca
2+ load required to induce MPTP opening. Here we manipulated mitochondrial phospholipid composition by
supplementing the diet with DHA, ARA or combined DHA+ARA in rats for 10 weeks. There were no effects on cardiac
function, or respiration of isolated mitochondria. Analysis of mitochondrial phospholipids showed DHA supplementation
increased DHA and displaced ARA in mitochondrial membranes, while supplementation with ARA or DHA+ARA increased
ARA and depleted linoleic acid (18:2n6). Phospholipid analysis revealed a similar pattern, particularly in cardiolipin.
Tetralinoleoyl cardiolipin was depleted by 80% with ARA or DHA+ARA supplementation, with linoleic acid side chains
replaced by ARA. Both the DHA and ARA groups had delayed Ca
2+-induced MPTP opening, but the DHA+ARA group was
similar to the control diet. In conclusion, alterations in mitochondria membrane phospholipid fatty acid composition caused
by dietary DHA or ARA was associated with a greater cumulative Ca
2+ load required to induced MPTP opening. Further, high
levels of tetralinoleoyl cardiolipin were not essential for normal mitochondrial function if replaced with very-long chain n3
or n6 PUFAs.
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Introduction
Cardiac muscle is densely packed with mitochondria, which are
essential to support the high rate of ATP generation needed for
contractile function. Mitochondria also are important for cell
survival, as under conditions of stress they can depolarize and
trigger cell death through the opening of the mitochondrial
permeability transition pore (MPTP). The structure and regulation
of the MPTP is not well understood [1,2]. We recently found that
increased long chain n3 polyunsaturated fatty acid (PUFA) and
depletion of n6 PUFA in mitochondrial membrane phospholipids
induced by high intake of docosahexaenoic acid (DHA; 20:6n3)
were associated with resistance to Ca
2+-induced MPTP opening
[3–5]. Long chain PUFAs, specifically DHA and arachidonic acid
(ARA; 20:4n6), are structurally distinguished from less unsaturated
fatty acids such as oleic acid (18:1n9) or linoleic acid (18:2n6) by
repeating double bonds that produces a highly flexible chain and a
more fluid membrane [6]. DHA is the most unsaturated PUFA
commonly found in mammals, followed by eicosapentaenoic acid
(EPA; 20:5n3) and ARA. DHA supplementation has shown
promise as a means to prevent and treat heart failure, which may
be partially mediated by improvements in mitochondrial function
[7–9].
ARA is depleted by the increase in membrane phospholipid
DHA content induced by dietary DHA supplementation. This
could be beneficial, as ARA is a precursor of inflammatory
eicosanoids, and can also trigger MPTP opening when released
from cell membranes by phospholipase A [10,11]. Thus the
greater Ca
2+ load required to induce MPTP opening with DHA
supplementation may occur secondary to lowering ARA in
membrane phospholipids. If true, then an increase in ARA in
mitochondrial membrane phospholipids above normal levels is
predicted to increase MPTP opening.
Like other cardiac membranes, mitochondrial phospholipids are
mainly comprised of phosphotidylethanolamine (PE) and phos-
photidylcholine (PC), however they are unique in that they contain
the tetra-acyl phospholipid cardiolipin (CL). CL comprises 15–
20% of the mass of total mitochondrial phospholipid [12].
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inherited defect in CL synthesis, results in severe mitochondrial
dysfunction and cardiomyopathy [13]. Linoleic acid is the main
fatty acyl moiety in CL, with 60–80% of CL being tetralinoleoyl
CL (L4CL) in cardiac mitochondria in humans, dogs and rats
[12,14,15]. It has been proposed that high levels of L4CL are
essential for optimal mitochondrial function in the heart [12].
Evidence to the contrary comes from the mouse heart, where
L4CL comprises only 22% of the total CL [14], and is replaced by
CL species that contain DHA (53% of total CL) [14,15]. A
decrease in the total CL in cardiac mitochondria and less L4CL
has been observed in acquired cardiac pathologies such as
hypertension-induced hypertrophy and heart failure in rodents
[12], but not dogs [16]. Importantly, there is also evidence that
high intake of fish oil rich in DHA can increase CL in heart
mitochondria [3,17,18], though this is not a consistent finding [5].
The effect of ARA intake on CL has not been reported, but
presumably would increase ARA incorporation into all mitochon-
drial phospholipids and could alter mitochondrial function.
In the present investigation we used pharmacological levels of
DHA and ARA (2.5% of energy intake [19,20]), well above those
consumed in food by humans, to manipulated cardiac mitochon-
drial phospholipid composition, and assessed the subsequent
effects on respiratory function and susceptibility to MPTP opening
in isolated cardiac mitochondria. We hypothesized that replacing
linoleic acid with either DHA or ARA in mitochondrial
membrane phospholipids would not adversely affect mitochondria
respiratory function in the absence of stress, but that ARA would
increase susceptibility to Ca
2+-induced MPTP opening. We
further hypothesized that dietary ARA supplementation would
dramatically increase ARA in mitochondrial phospholipids, and
specifically decrease L4CL and increase incorporation of ARA side
chains of CL. Rats were fed diets supplemented with DHA, ARA
or combined DHA+ARA at physiologically relevant doses.
Cardiac contractile function was evaluated, and cardiac mito-
chondria were analyzed for susceptibility to MPTP opening, total
phospholipid fatty acid composition, and individual molecular
species within each phospholipid class by mass spectrometry.
Results
Morphometric data
All groups had similar weight gain and food consumption, and
there were no significant differences in body, heart or liver mass
between dietary treatments (Table 1). There was no effect of diet
on LV dimensions as measured by echocardiography (Table 1).
Mitochondrial Phospholipid Composition
The fatty acid composition of total mitochondrial phospholipids
was dramatically altered by all 3 dietary interventions (Table 2,
Figure 1). Both diets containing DHA raised mitochondrial
phospholipid DHA content approximately 2-fold, while ARA
supplementation led to a 70% reduction in DHA. Conversely,
ARA supplementation increased membrane ARA by ,50% while
DHA supplementation decreased ARA by ,50%. Combined
DHA+ARA supplementation maintained ARA content at levels
seen in the control diet group. Membrane EPA was increased from
undetectable levels to approximately 1% by both the DHA and
ARA diets, but was undetectable with the combined DHA+ARA
diet. Oleate was only slightly affected by the different diets
(Table 2). Most notably, the double bond index, a measure of
membrane unsaturation, and the n3/n6 ratio were both
dramatically decreased with ARA supplementation and preserved
with the DHA+ARA diet.
Phospholipid classes were not changed by diet to any significant
extent, except for a decrease in CL and mono-lyso-CL (MLCL)
with ARA and DHA+ARA supplementation (Table 3). There was
also a small increase in PC with ARA supplementation. In
contrast, analysis of side chain composition within each phospho-
lipid class revealed some dramatic diet-induced changes in fatty
acyl groups (Table S1, Figure 2, S1,S2,S3,S4,S5). Dietary
supplementation with DHA increased DHA in PE, PI and PC,
as assessed by mass spectrometry. The increase in DHA was
determined by the increase in peak intensity at molecular masses
that corresponded to the calculated theoretical mass based on
probable side chains (Table S1). Similarly, ARA was increased by
the ARA and DHA+ARA diets in PE, PG, PC, CL and MLCL.
Table 1. Body mass, organ mass, and LV dimensions.
Control DHA ARA DHA+ARA
Group size: 15 14 15 15
Terminal Body Mass (g) 501611 500665 0 2 695 0 5 69
LV Mass (g) 0.89560.021 0.91760.017 0.90260.020 0.93860.024
LV/Tibia length (g/cm) 0.2260.01 0.2360.00 0.2260.01 0. 2360.01
RV Mass (g) 0.26260.011 0.26760.004 0.26860.004 0.26960.008
Biatrial Mass (g) 0.08360.003 0.09160.006 0.09260.005 0.08360.003
Liver Mass (g) 13.660.6 12.560.3 13.360.4 14.160.5
Mitochondrial Yield (mg mito protein/g wet wt) 14.5760.69 14.1760.64 14.4260.86 15.5261.00
End-systolic diameter (mm) 0.7760.01 0.7660.02 0.7760.02 0.8160.02
End-diastolic diameter (mm) 0.4360.02 0.4360.01 0.4360.02 0.4860.02
Fractional shortening 0.4560.02 0.4360.02 0.4460.02 0.4160.05
Ejection fraction (%) 83.061.4 81.361.5 81.961.8 79.261.4
Malonaldehydes+Hydroxyalkenals (nmols/mg protein) 0.5660.04 0.5860.04 0.5360.03 0.6860.04*{
Data are the mean 6 SEM. LV, left ventricle. RV, right ventricle.
*p,0.05 vs CTRL.
{p,0.05 vs ARA.
doi:10.1371/journal.pone.0034402.t001
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their effect on phospholipid fatty acid composition, with DHA
alone depleting ARA from CL, PE and PC (Figures 2 and 3, Table
S1). Conversely, dietary ARA depleted DHA from PE and PC.
Interestingly, the combination of DHA and ARA restored both
DHA and ARA in PE and PC. Further, it gave a profile that was
largely similar to the diet with ARA alone. This is illustrated in the
mass spectrum (Figure 2 for CL, and Figures S1,S2,S3,S4,S5 for
other phospholipids), which shows that treatment with ARA and
DHA+ARA resulted in a profound shift in the profile, with an
increase in peak intensities for higher molecular weight species.
On the other hand, DHA had far less of an effect on the profile. As
noted above, treatment with ARA or DHA+ARA, but not DHA
alone, depleted linoleic acid content from total phospholipids by
,50% (Figure 1), and the analysis of individual phospholipid
species revealed that this occurred in CL, MLCL, PE PG and PC
(Figure 3, Table S1).
Lipid Peroxidation
DHA+ARA supplementation significantly increased myocardial
content of malonaldehydes and hydroxyalkenals compared to the
control and ARA groups (p,0.05), and showed a strong trend
toward being higher than the DHA group (p=0.071).
Urine Thromboxane B2
TBX B2 is a metabolite of pro-inflammatory thromboxane A2,
and is excreted by the kidneys. Both diets containing ARA
increased TBX B2 excretion significantly by two- to three-fold
compared to CTRL and DHA diets (29.062.9 and 22.862.6 pg/
mmol creatine for CTRL and DHA groups, vs. 63.366.7 and
50.1164.8 for ARA and DHA+ARA groups, respectively;
p,0.05)
Mitochondrial Respiration
There was no effect of diet on State 3 or State 4 respiration, or
on the respiratory control ratio (RCR) with any of the substrates
used (Table 4).
Ca
2+ Retention Capacity
Mitochondria from rats supplemented with DHA or ARA alone
had significantly enhanced Ca
2+ retention capacity compared to
CTRL animals, as reflected by significantly lower extramitochon-
drial [Ca
2+] for a given cumulative Ca
2+ load with all substrates
except palmitoylcarnitine+malate (Figure 4). Surprising, dietary
supplementation with the combination of DHA+ARA resulted in
greater sensitivity to Ca
2+ MPTP opening, as reflected in a higher
extramitochondrial [Ca
2+] with all substrates when compared to
either CTRL, DHA or ARA with pyruvate+malate as a substrate
(Figure 4).
To assess the possible role of Ca
2+-dependent and –independent
phospholipase A2 in Ca
2+ induced MPTP opening, we assessed the
effects of addition of aristolochic acid and bromoenolactone,
inhibitors of phospholipase A2, on the relationship between
cumulated Ca
2+ load and extramitochondrial [Ca
2+]. This shifted
the relationship to the right in mitochondrial from the CTRL and
DHA+ARA groups, but not in the DHA or ARA groups (Figure 5).
Mitochondrial Swelling
The decrease in absorbance at 520 nm following the addition of
Ca
2+ to isolated mitochondria was used as a measure of MPTP
opening. DHA supplementation attenuated the in response to
2 mmols Ca
2+/mg mitochondrial protein compared to CTRL,
ARA and DHA+ARA groups (Figure 6). Both DHA and ARA
supplementation attenuated the decrease in absorbance in
Figure 1. Cardiac mitochondrial phospholipid fatty acid
composition. Values are expressed as percentage of total fatty acids.
Data are mean6SEM. CTRL, n=7. DHA, n=7. ARA, n=5. DHA+ARA,
n=6.
doi:10.1371/journal.pone.0034402.g001
Table 2. Mitochondrial phospholipid fatty acid composition expressed as molar percent of total phospholipid fatty acid.
Fatty Acid CTRL DHA ARA DHA+ARA
Palimate (C16:0) 16.060.4 17.761.0 14.860.6
# 16.860.7
Stearate (C18:0) 25.460.7 21.562.2 27.264.1 25.760.6
Oleate (C18:1n9) 4.160.3 3.360.3 3.660. 2.760.1*
Vaccenic acid(C18:1n7) 4.360.1 3.360.3* 4.160.2
# 3.660.2
Linoleic acid (C18:2n6) 20.560.6 21.761.8 11.460.5
# 11.462.1
#
Arachidonic acid (20:4n6) 19.160.3 11.562.0* 32.261.3*
# 17.261.8
Eicosapentaenoic Acid (20:5n3) BQL 1.560.3* 0.960.4* BQL
Docosahexanoic acid (22:6n3) 10.960.7 20.760.7* 3.162.0*
# 21.460.9*
{
Double Bond Index 19164.0 221681 8 3 615 22765*
{
n3/n6 ratio 0.2760.01 0.7360.04 0.1560.03
# 0.7360.04*
{
Data are means6SEM. CTRL, n=7. DHA, n=7. ARA, n=5. DHA+ARA, n=6.
*p,0.05 vs CTRL.
#p,0.05 vs DHA,
{p,0.05 vs ARA; BQL, Below Quantifiable Limit.
doi:10.1371/journal.pone.0034402.t002
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2+/mg mitochondrial protein com-
pared to CTRL.
Discussion
Here we present the novel observation that a large increase in
either DHA or ARA in mitochondrial membrane phospholipids is
associated with a significant increase in the mitochondrial capacity
for Ca
2+ retention, an index of MPTP opening. Further, we
showed that L4CL is not essential for normal mitochondrial
function if replaced with very-long chain n3 or n6 PUFA. On the
other hand, the extreme increase in the sum of ARA and DHA
accompanied by depletion of linoleic acid that occurred with the
DHA+ARA diet was associated with increased susceptibility to
Figure 2. Representative mass spectra of cardiac mitochondrial CL species.
doi:10.1371/journal.pone.0034402.g002
Table 3. Composition of cardiac mitochondrial membrane by phospholipid class.
Phospholipid Class (mol% of total) CTRL DHA ARA DHA+ARA
CL 8.560.2 8.560.2 7.060.1
*# 7.260.1
*#
MLCL 0.560.0 0.560.0 1.060.1
*# 0.760.0
*#{
PE 47.760.5 48.260.6 46.160.5
# 46.960.5
PI 3.960.1 3.760.1 3.860.1 4.160.1
PG 0.660.0 0.660.1 0.760.1
# 0.660.0
PC 38.760.5 38.660.6 41.560.5
*# 40.560.6
Data are means6SEM. CTRL, n=13. DHA, n=12. ARA, n=14. DHA+ARA, n=14. CL, cardiolipin. MLCL, monolysocardiolipin. PE, phosphotidylethanolamine. PI,
phosphotidylinositol. PG, phosphotidylglycine. PC, phosphotidylcholine.
*p,0.05 vs CTRL.
#p,0.05 vs DHA.
doi:10.1371/journal.pone.0034402.t003
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DHA and ARA with low linoleic acid in membrane phospholipids
is detrimental.
Our data do not support our initial hypothesis that the
beneficial effect of DHA on MPTP opening is due to decreased
membrane phospholipid ARA content. ARA has been identified
as an MPTP inducer [21] and increased free ARA in cells can
result in necrosis or apoptosis [10,22,23]. For example, inhibition
of mitochondrial Ca
2+-independent phospholipase A2c, which is
predicted to lower free ARA, reduced Ca
2+-induced MPTP
opening, mitochondrial phospholipid loss and reduced infarct size
following I/R [23]. Similarly, Penzo and colleagues demonstrated
that ARA released by Ca
2+-dependent cytosolic phospholipase A2
activation triggers MPTP opening and cell death [11]. We found
that dual inhibition of Ca
2+-dependent and independent phos-
pholipase A2 enzymes with a combination of aristolochic acid and
bromoenolactone, respectively, resulted in delayed Ca
2+-induced
MPTP in the mitochondria of control-fed rats. Interestingly, it also
provided a protective effect in the DHA+ARA group and altered
the calcium sensitivity back to control levels. Both control and
DHA+ARA groups, with phospholipase inhibition, are not
significantly different from either DHA or ARA groups. This
supports the conclusions made by previous studies in favor of a
role for ARA release by phospholipases in inducing MPTP
opening. However, we also saw that ARA supplementation does
not induce MPTP opening as this hypothesis would predict, but
rather delays it with no added benefit of phospholipase inhibition.
Similarly, in the DHA group phospholipase inhibition did not
provide additional resistance in MPTP opening. Thus, it is
unlikely that modulation of free ARA explains the downward shift
in the relationship between cumulative Ca
2+ load and extramito-
chondrial [Ca
2+] induced MPTP opening seen with ARA or DHA
supplementation.
Although ARA supplementation provided a protective effect on
MPTP opening, it also increased thromboxane production. This
increase in inflammatory mediators also was seen in the combined
DHA+ARA diet. The potential for ARA to modulate inflamma-
tion has been described by others [24]. Prostaglandin E2 synthesis
can be increased by dietary supplementation with ARA, and this is
modulated by other saturated fatty acids [25–27]. However, given
the potential for ARA to increase inflammation, it is necessary to
reconsider its use as a dietary supplement to prevent MPTP,
especially in diseases that have an inflammatory component to
their pathology, such as heart failure.
The combined DHA+ARA diet did not provide the protective
effect of the diets containing DHA or ARA alone, and was
detrimental to MPTP opening and increased inflammatory
markers. The very high dose of PUFA provided by this diet
increases membrane unsaturation to very high levels. Taking into
account the high susceptibility of the highly unsaturated fatty acids
to undergo peroxidation, and their proximity in the mitochondria
to an ample source of reactive oxygen species, the DHA+ARA diet
may increase MPTP susceptibility due to increased lipid
peroxidation. This is further supported by the increase in
malonaldehydes and hydroxyalkenals seen in the combined diet.
Thus, the optimal dose of PUFAs might be below the threshold
where increased lipid peroxidation outweighs the benefits provided
by increasing membrane unsaturation. A less likely possibility is
that there is negative interaction between DHA and ARA that
Figure 3. Cardiac mitochondrial phospholipid species composition. Values are expressed as percentage of total measured. Data are
mean6SEM. CTRL, n=14. DHA, n=13. ARA, n=13. DHA+ARA, n=14. *p,0.05 vs CTRL. #p,0.05 vs DHA. {p,0.05 vs ARA.
doi:10.1371/journal.pone.0034402.g003
Table 4. Mitochondrial Respiration.
Control DHA ARA DHA+ARA
Pyruvate+Malate
State 3 225617 239622 245621 236619
State 4 (2oligomycin) 51.662.0 51.363.1 47.362.6 49.763.7
State 4 (+oligomycin) 36.864.1 44.864.3 33.763.6 41.164.3
RCR (2oligomycin) 4.560.4 4.760.4 4.860.2 5.260.4
RCR (+oligomycin) 6.860.8 5.860.6 8.160.9 6.260.6
Palmityl-
CoA+Carnitine+Malate
State 3 221616 203614 200614 196613
State 4 (2oligomycin) 45.662.9 53.465.0 46.062.6 46.662.9
State 4 (+oligomycin) 40.963.8 41.264.7 36.462.8 42.964.3
RCR (2oligomycin) 5.060.3 4.160.4 4.360.3 4.560.4
RCR (+oligomycin) 5.760.4 6.461.7 5.860.5 5.160.6
Succinate+Rotenone
State 3 392616 398619 360622 393625
State 4 (2oligomycin) 122.763.6 120.167.3 111.664.7 108.266.9
State 4 (+oligomycin) 107.864.9 123.967.8 100.068.3 123.667.0
RCR (2oligomycin) 3.260.1 3.460.2 3.760.2 3.260.2
RCR (+oligomycin) 3.760.1 3.360.1 3.860.3 3.260.1
Data are the mean 6 SEM. CTRL, n=14. DHA, n=13. ARA, n=13. DHA+ARA,
n=14. All Rates are expressed in ng atoms O?mg
21?min
21. The RCR, defined as
the ratio of State 3 to State 4 respiration rate, was calculated from the State 4
rate with oligomycin.
doi:10.1371/journal.pone.0034402.t004
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studies should compare DHA alone and ARA alone to
DHA+ARA at an equivalent dose of total PUFA.
We did not observe any differences in mitochondrial respiration
with DHA supplementation with any of the substrates tested. We
had previously shown that DHA supplementation decreases state 4
respiration with pyruvate+malate as substrates [3]. A subsequent
study failed to replicate this finding [4], and again, we saw no
difference in state 4 respiration in this study. The larger sample
size used here allows for more confidence in concluding that DHA
does not affect non-phosphorylating respiration in the healthy
mitochondria compared to the CTRL diet. This, however, may
not apply to mitochondria that have been stressed. Given DHA’s
protective effect in heart failure [7–9], we expect that DHA
Figure 4. Effect of diet on Ca
2+ retention capacity in the presence of different respiratory substrates. Data are mean6SEM. CTRL, n=9.
DHA, n=9. ARA, n=9. DHA+ARA, n=10.
doi:10.1371/journal.pone.0034402.g004
Figure 5. Effect of phospholipase A2 inhibition on the Ca
2+ retention capacity. Data are mean 6SEM. CTRL, n=9. DHA, n=9. ARA, n=9.
DHA+ARA, n=10. CTRL vehicle vs CTRL inhibitors p,0.006. DHA+ARA vehicle vs DHA+ARA inhibitors p,0.01.
doi:10.1371/journal.pone.0034402.g005
Dietary PUFA and Mitochondrial Function
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with heart disease.
There are limitations to the present investigation that need to be
addressed. First, we assess only subsarcolemmal mitochondria, and
not the whole population of cardiac mitochondria that includes the
subpopulation of cardiac mitochondrial found amongst the fibrils
(‘‘interfibrillar mitochondria’’). Isolation of total cardiac mito-
chondria requires incubation with a protease (trypsin) to disrupt
the fibrils and release interfibrillar mitochondria, however we did
not want to risk potential damage to mitochondrial proteins by this
procedure. The effects protease digestion on mitochondrial Ca
2+
uptake or MPTP opening is not known, thus we did not wish to
introduce this potential confounding variable. We have previously
found that there are no differences in membrane phospholipid
fatty acid composition between interfibrillar and subsarcolemmal
cardiac mitochondria in rats fed a standard low n-3 PUFA lab
chow, or in the changes in mitochondrial membrane phospholip-
ids caused by long term dietary supplementation with DHA or
eicosapentaenoic acid (EPA) [4,5]. This suggests that the changes
we observed in subsarcolemmal mitochondria in the present study
would very likely be duplicated in interfibrillar mitochondria. A
second important limitation is that lack of measurement of the
initial mitochondrial [Ca
2+], as dietary supplementation with
DHA or ARA could affect the residual Ca
2+ in the mitochondrial
matrix following isolation. Decreased initial matrix [Ca
2+] could
increase mitochondrial Ca
2+ uptake capacity and give the
impression of delayed PTP opening in response to successive
Ca
2+ additions. Our main conclusion regarding mitochondrial
Ca
2+ retention is that dietary supplementation with docosahex-
aenoic acid or arachidonic acid are associated with a greater
exogenous Ca
2+ load required to induce MPTP opening. We
know of no rationale to suggest there would be differences in the
initial [Ca
2+] among treatment groups, nevertheless there may be
differences that could affect the capacity for Ca
2+ retention.
Clearly future studies should assess this variable. Lastly, we did not
assess the effects of cyclosporin A on Ca
2+-induced MPTP opening
in the present investigation. In a previous study we found that
acute ex vivo treatment with cyclosporine A delayed Ca
2+-induced
MPTP opening, on rats fed a normal diet or with supplementation
with DHA+EPA or EPA, but not DHA alone [4,5]. Future studies
should compare the effects of ARA and DHA supplementation on
the delay in MPTP opening caused by cyclosporine A.
In summary, dietary supplementation with DHA or ARA
caused dramatic alterations in mitochondria membrane phospho-
lipid fatty acid composition, and delayed Ca
2+-induced MPTP
opening to approximately the same extent when compared to the
standard control diet. This suggests that the effect of DHA on
MPTP is most likely due to membrane unsaturation rather than
depletion of ARA. Furthermore, DHA+ARA supplementation
showed no added benefit, but rather sensitized MPTP to opening,
suggesting that a very large dose of long chain PUFA can be
detrimental. Finally, we found that high levels of L4CL were not
essential for normal mitochondrial function if replaced by very-
long chain n3 or n6 PUFAs.
Methods
Experimental Design
The animal protocol was conducted according to the Guideline
for the Care and Use of Laboratory Animals (NIH publication 85-
23) and was approved by the University of Maryland School of
Medicine Institutional Animal Care and Use Committee (Protocol
number 1009011). In accordance with this document, every effort
was made to prevent pain to the animal, and to aleviate pain with
anesthetic when it could potentially occur. Investigators were
blinded to treatment when measurements were performed. The
animals were maintained on a reverse 12-h light–dark cycle and all
procedures were performed in the fed state between 3 and 6 h
from the start of the dark phase. Male Wistar rats weighing 190–
200 g were fed a standard low fat diet (CTRL) or a modified
standard diet containing DHA or ARA at 2.5% of total caloric
intake, which corresponds to a human intake of approximately
5.5 g/day (calculated assuming an energy intake of 2000 kcal/day
and 9 kcal/g of fat) or a combined DHA+ARA diet at 5% of total
caloric intake. After 10 weeks of dietary treatment, rats were
anesthetized with isoflurane, urine was collected from the bladder,
and hearts were harvested for biochemical analysis and mito-
chondrial isolation. Urine was analyzed for creatinine and
thromboxane metabolites. Cardiac mitochondria were analyzed
for respiration, Ca
2+ retention capacity, Ca
2+ induced swelling and
membrane phospholipid composition as described below.
Diets
All diets were custom-manufactured (Research Diets Inc., New
Brunswick, NJ), and had 66% of total energy from carbohydrate
(54% of total energy from cornstarch and 12% from maltodextrin),
20% protein (casein supplemented with l-cystine) and 14% energy
from fat (see Table 5 for fatty acid composition). In the CTRL
diet, the fat was made up of 71.5% cocoa butter, 17.1% soybean
oil, 7.2% palm oil, 2.8% safflower oil and 1.4% linseed oil. The
DHA diet contained 5.75% of total energy from DHASCO
(Martek Inc, Columbia, MD, USA) that was comprised of 43.6%
DHA by, in place of part of the cocoa butter. The DHASCO oil
was free from ARA. The ARA diet had 6.25% of energy from
ARASCO (Martek Inc, Columbia, MD, USA) that was comprised
of 40.1% ARA by mass partially replaced cocoa. The ARASCO
oil was free from DHA. The DHA+ARA diet had both the DHA
and ARA enriched oils added at 5.75 and 6.25% of energy
respectively. DHASCO and ARASCO oils were purified from
algae and contained ascorbyl palmitate (250 ppm) and tocopherols
(250 ppm) to prevent lipid oxidation, which was less than
0.5 meq/kg at the time of manufacture of the diet. All diets were
supplemented with the same amount of vitamins (Vitamin Mix
V10001, 10 g/kg), minerals (Mineral Mix S10026, 10 g/kg),
cellulose (50 g/kg) and choline (2 g/kg). It is important to note
that the levels of DHA and ARA used in this study are equivalent
to ,5.5 g/day in humans (calculated assuming an energy intake of
2000 kcals/day). Tthus the dose of DHA and ARA use in this
Figure 6. Effect of diet on mitochondrial Ca
2+ induced swelling.
Average decrease in absorbance 900 seconds after Ca
2+ addition. Data
are mean 6 SEM. CTRL, n=9. DHA, n=8. ARA, n=9. DHA+ARA, n=9.
*p ,0.05 vs CTRL.
doi:10.1371/journal.pone.0034402.g006
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consumed in food (,0.0.5 to ,0.7 g/day of each) [19,20].
Echocardiography
Since dietary lipids can effect cardiac chamber size and
contractile function, we assessed LV dimensions in anesthetized
rats using a high resolution small animal imaging system (model
Vevo 770, with transducer model RMV 716, VisualSonics Inc.,
Toronto, Canada), as previously described in detail [5]. Briefly,
rats were anesthetized with isoflurane by mask, placed supine on a
heated platform, and 2-dimensional cine loops and guided M-
mode frames were acquired from the short and long axis.
Measurements were made off line using software resident on the
system, with the investigator blind to the treatment.
Metabolic and Biochemical Parameters
Lipid peroxidation was measured in whole tissue homogenate
using a commercially available kit reacting to malonaldehydes and
4-hydroxyalkenals (Oxford Biomedical Research, MI, USA).
Urine creatinine and thromboxane B2 were measured using
commercially available kits (Cayman Chemicals, MI, USA)
Mitochondrial Preparation
Subsarcolemmal mitochondria were isolated as previously
described [3,26]. LV tissue (approximately 500 mg) was thor-
oughly rinsed and cut immediately following excision of the heart
and placed in Ca
2+ free ice-cold modified Chappel-Perry buffer
(100 mM KCl, 50 mM MOPS, 5 mM MgSO4, 1 mM Na2ATP,
1 mM EGTA, 2 mg/ml BSA). LV tissue was dissected, rinsed
again, blotted dry, then minced in ice-cold buffer. Prior to
homogenization, the buffer was replaced twice to remove blood
contamination. The tissue was homogenized in 1:10 (wt/vol)
Chappel-Perry buffer, and subsarcolemmal mitochondria were
then isolated and purified by differential centrifugation. Mito-
chondrial protein concentration was measured by the Lowry
method using bovine serum albumin (BSA) as a standard.
Membrane Lipid Composition
Cardiac phospholipid fatty acid composition was assessed in
isolated cardiac mitochondria homogenates by gas chromatogra-
phy coupled with mass spectrometry according to a modification
of the transesterification method as previously described [28].
Individual phospholipid species were quantified after extraction
using the method of Christiansen in the presence of internal
standard [29]. The resultant extract was subjected to silica gel
chromatography to harvest phospholipids [30]. The phospholipid
classes were separated on a normal-phase HPLC coupled to a
LCQ Deca (Thermo Scientific) ion trap mass spectrometer.
Quantitation was performed by interpolation to standard curves
for each class of phospholipids. (Kim J. & Hoppel C.L.,
manuscript submitted). Mass spectrometric data was adjusted for
natural abundance using predicted molecular composition from
the RCM Lipid Calculator (http://pharmacology.ucdenver.edu/
lipidcalc/Default.aspx) and the GENEBIO SmileMS Low Preci-
sion Isotope Distribution Calculator (http://research.smilems.
com/molecule-tk/moleculeUtils/isotoperatio).
Mitochondrial respiration
Mitochondrial oxygen consumption was measured using a
Clark-type oxygen electrode (Qubit Systems, Ontario, Canada).
Mitochondria (0.25 mg protein) were suspended in respiration
buffer (0.5 ml; 100 mM KCl, 50 mM MOPS, 5 mM KH2PO4
1 mM EGTA, and 0.5 mg fatty acid-free BSA) at pH 7.4 and
37uC [31]. State 3 (ADP-stimulated) and state 4 (non-phosphor-
ylating) respiration were measured with 3 different sets of
substrates: pyruvate+malate (10 and 5 mM, respectively) and
palmityl-CoA+carnitine+malate (40 mM, 5 mM and 5 mM,
respectively) to assess respiration through complex I–IV, and
succinate+rotenone (10 mM and 7.5 mM, respectively) to assess
respiration through complex II–IV of the ETC exclusively.
Oligomycin was also used to inhibit mitochondrial ATP synthase
and assess state 4 respiration.
Mitochondrial Ca
2+ Retention Capacity
Mitochondrial Ca
2+ retention was assessed using a 96-well
fluorescence plate reader (FLUOstar Optima, BMG Labtech,
Germany) as previously described [3]. 25 mg of mitochondria per
well were resuspended in 200 mL of the same buffer used above,
but with varying substrates and inhibitors; either glutamate+ma-
late (10 and 5 mM, respectively), pyruvate+malate (10 and 5 mM,
respectively), palmitoylcarnitine+malate (40 mM and 5 mM,
respectively) or succinate (10 mM) with rotenone (7.5 mM), and
glutamate+malate with phospholipase A2 inhibitors bromoeno-
lactone (5 mM) and aristolochic acid (5 mM). Extramitochondrial
Ca
2+ was monitored using 1 mM Calcium Green 5N and
fluorescence was measured at 485 nm and 538 nm for excitation
and emission wavelengths respectively. Automated additions of 25
nmoles Ca
2+/mg mitochondrial protein were performed at regular
7 minute intervals and fluorescence measured every 17 seconds
for 160 min at 37uC.
Ca
2+-Induced Mitochondrial Swelling
Light scattering, an index of Ca
2+-induced mitochondrial
swelling, was monitored using a 96 well spectrophotometric plate
reader (SpectraMax, Molecular Devices, USA) [3]. Briefly, 25 mg
Table 5. Fatty acid compositions of the rodent diets
expressed as the molar percent of total fatty acids in the diet.
Fatty Acid Diet
CRTL DHA ARA DHA+ARA
C12:0 3.4 1.5 3.4 1.5
C14:0 1.1 3.6 1.6 4.1
C16:0 21.7 14.6 16.2 9.5
C16:1 0.2 1.4 0.1 1.4
C18:0 25.8 14.2 16.1 5.3
C18:1n-9 30.3 28.8 23.4 21.9
C18:2n6 13.9 14.7 15.2 14.1
C18:3n3 2.2 2.2 2.3 2.4
C20:4n6 - - 18.3 18.4
C20:5n3 - 0.3 - 0.3
C22:6n3 - 17.8 - 18.3
Total saturated 52 34 37 20
Total mono-sat 30 30 23 23
Total n3 2.2 20 2.3 21
Total n6 14 15 33 32
n6/n3 6.3 0.7 15 1.5
PUFA/saturated 0.3 1.0 1.3 2.6
All diets had 14% of total energy from fat, 20% from protein and 66% from
carbohydrates.
doi:10.1371/journal.pone.0034402.t005
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used for the Ca
2+ retention capacity assay. Baseline absorbance at
540 nm was read at 7 second intervals for 2 min, then either 50 or
100 nmoles of Ca
2+ was rapidly added to the wells and the
absorbance was read for 15 min at 37uC.
Statistical Analyses
Mean values are presented 6 SEM, and the level of significance
was set at p,0.05. Differences among dietary treatment groups
were assessed using a One-Way ANOVA with Holm-Sidak post
hoc test. Data sets that were not normally distributed were
analyzed with a Kruskal-Wallis One-Way ANOVA on Ranks,
with a Dunn’s post hoc test. The response of isolated mitochondria
to progressive additions of Ca
2+ were assessed by comparing the
extramitochondrial Ca
2+ concentrations using a two way repeated
measures ANOVA followed by a Holm-Sidak post hoc test for
main effects and interactions.
Supporting Information
Figure S1 Representative spectra for mono-lyso-cardio-
lipin (MLCL).
(TIF)
Figure S2 Representative spectra for phosphotidyletha-
nolamine (PE).
(TIF)
Figure S3 Representative spectra for phosphotidylcho-
line (PC).
(TIF)
Figure S4 Representative spectra for phosphotidylino-
sitol (PI).
(TIF)
Figure S5 Representative spectra for phosphotidylgly-
cerol (PG).
(TIF)
Table S1 Phospholipid composition of mitochondrial
membranes.
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